drug

MDMA 120mg

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Anya Bershad, MD, PhD
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
Tolerability of MDMA in Schizophrenia
NCT05770375Phase 1, Phase 2Recruiting

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Anya Bershad, MD, PhD
company
trial
Tolerability of MDMA in Schizophrenia
PHASE1, PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication